Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD Cirrhosis”

201 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 201 results

Not applicableStudy completedNCT02477462
What this trial is testing

Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

Who this might be right for
Primary Biliary Cirrhosis
University of California, Davis 124
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00266019
What this trial is testing

Weight Management in Nonalcoholic Steatohepatitis

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Not applicableUnknownNCT05239260
What this trial is testing

Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

Who this might be right for
NAFLD/MAFLDLiver FibrosisCMR
Medical University of Vienna 150
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Large-scale testing (Phase 3)Study completedNCT03439254
What this trial is testing

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
Intercept Pharmaceuticals 919
Early research (Phase 1)Study completedNCT04857437
What this trial is testing

Study in Healthy Adults Evaluating PF-07202954

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Fibrosis
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableNot Yet RecruitingNCT07585526
What this trial is testing

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160
Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Early research (Phase 1)Study completedNCT03445208
What this trial is testing

Experimental Medication BMS-986036 Given to Healthy Participants

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease+1 more
Bristol-Myers Squibb 30
Not applicableUnknownNCT05849220
What this trial is testing

Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.

Who this might be right for
NAFLD Cirrhosis
Institute of Liver and Biliary Sciences, India 144
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Not applicableStudy completedNCT07294963
What this trial is testing

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar 45
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
The Cleveland Clinic 120
Early research (Phase 1)Study completedNCT04643795
What this trial is testing

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

Who this might be right for
Hepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 87
Not applicableStudy completedNCT04561804
What this trial is testing

NAFLD and Liver Fibrosis in Obese Adolescents

Who this might be right for
Liver FibrosisLiver SteatosisWeight Loss
Tel-Aviv Sourasky Medical Center 100
Next Page